400-82-025
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 00mg | ￥ ĠĿĿĨĿĿ | > 0 | > 0 | -- | ￥ ĠĿĿĨĿĿ | - + | |||
| 250mg | ￥ ĠƘĠĨĿĿ | > 0 | > 0 | -- | 2 | ￥ ĠƘĠĨĿĿ | - + | ||
| g | ￥ ŕŮĠĨĿĿ | > 0 | > 0 | -- | 2 | 2 | ￥ ŕŮĠĨĿĿ | - + | |
| 5g | ￥ ĠƘijĠĨĿĿ | 4 | > 0 | -- | 2 | ￥ ĠƘijĠĨĿĿ | - + | ||
| 0g | ￥ ĒǛŮĿĨĿĿ | 2 | > 0 | -- | -- | -- | -- | ￥ ĒǛŮĿĨĿĿ | - + |
| 25g | ￥ ƘƣŕĠĨĿĿ | -- | 6 | -- | -- | -- | -- | ￥ ƘƣŕĠĨĿĿ | - + |
| 00g | ￥ ĠŕĒĿǛĨĿĿ | -- | -- | -- | -- | -- | ￥ ĠŕĒĿǛĨĿĿ | - + | |
| 500g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 000g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
.05
[]. Asakawa T, et al. A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-22), is effective in diabetic rats with sulfonylurea-induced secondary failure. Life Sci. 200 Jul ;85(-4):22-6.
[2]. Feng J, et al. Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. J Med Chem. 200 May ;50(0):22-00.
[]. Hao FL, et, al. The neurovascular protective effect of alogliptin in murine MCAO model and brain endothelial cells. Biomed Pharmacother. 20 Jan;0:8-8.
[4]. Moritoh Y, et al. The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice. Eur J Pharmacol. 200 Jan 4;602(2-):448-54.
[5]. Ta NN, et al. DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP- expression by U histiocytes. Atherosclerosis. 200 Dec;2(2):42-5.
H02-H5-H-H5
P26-P264-P20-P2-P280-P02+P52-P04+P40-P05+P5+P8-P0-P62+P64-P40+P2-P405-P50
GHS0,GHS0
0
沪ICP备0645号
